Table 2.
All-cause mortality |
Breast cancer-specific mortality |
Non-breast cancer mortality |
|||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p valuea | HR | 95% CI | p valuea | HR | 95% CI | p valuea | |
Body mass index (kg/m2) | |||||||||
< 18.5 | 1.31 | 0.80–2.15 | 0.33 | 0.12–0.93 | 1.78 | 1.09–2.95 | |||
18.5–24.9 | 1 (ref) | 1 (ref) | 1 (ref) | ||||||
25–29.9 | 0.82 | 0.67–1.01 | 0.87 | 0.40–1.19 | 0.82 | 0.63–1.06 | |||
30–34.9 | 0.75 | 0.59–0.95 | 0.94 | 0.68–1.30 | 0.67 | 0.47–0.93 | |||
≥35 | 0.85 | 0.67–1.08 | 0.93 | 0.64–1.35 | 0.88 | 0.64–1.21 | |||
Per 5 kg/m2 Δ | 0.93 (0.87–0.95) | 0.02 | 0.98 (0.94–1.02) | 0.42 | 0.90 (0.82–0.99) | 0.04 |
Model adjusted for age, American Joint Commission on Cancer (AJCC) stage, insurance type, poverty in census tract of residence, education levels in census tract of residence, urbanicity of residence area, tumor grade, hormone receptor status, and comorbidity level. Survey sampling was stratified by tumor registry and by race/ethnicity
p value for trend, calculated from model using BMI as a continuous measure